Indication
Post-Acute COVID-19
5 clinical trials
5 products
Clinical trial
Digital Symptom Tracking and Wellness in Long COVID Patients Using Endourage Targeted Wellness Formula C™ Sublingual DropsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
An Exploratory, Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of an Anti-SARS-CoV-2 Monoclonal Antibody and Response to Treatment in Individuals With Long COVID (outSMART-LC)Status: Active (not recruiting), Estimated PCD: 2025-07-31
Product
AER002Clinical trial
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)Status: Active (not recruiting), Estimated PCD: 2023-06-15
Product
Stellate Ganglion BlockClinical trial
Placebo-Controlled, Randomized Trial of Ensitrelvir (S-217622) for Viral Persistence and Inflammation in People Experiencing Long COVID (PREVAIL-LC)Status: Recruiting, Estimated PCD: 2025-03-31
Product
EnsitrelvirClinical trial
Genetic Risk Factors for Multi-system Inflammatory Syndrome in Children and Pediatric Post COVID ConditionStatus: Recruiting, Estimated PCD: 2024-01-31
Product
Saliva collection